Janux Therapeutics, Inc.

NasdaqGM:JANX Rapporto sulle azioni

Cap. di mercato: US$2.6b

Janux Therapeutics Proprietà

Chi sono i principali azionisti e gli insider hanno acquistato o venduto?

Recenti transazioni insider

NasdaqGM:JANX Recenti transazioni di insider da parte di aziende o persone fisiche
DataValoreNomeEntitàRuoloAzioniPrezzo massimo
01 Nov 24SellUS$24,385,695Avalon Ventures, LLCCompany456,267US$55.26
01 Nov 24SellUS$391,382Sanford MadiganIndividual7,371US$53.12
01 Nov 24SellUS$243,671Jay LichterIndividual4,558US$53.51
01 Nov 24SellUS$1,730,817Tighe ReardonIndividual32,384US$53.82
01 Nov 24SellUS$334,250Sergio DuronIndividual6,306US$53.02
01 Nov 24SellUS$2,337,413Avalon Bio VenturesCompany43,734US$55.26
24 Oct 24SellUS$262,634Jay LichterIndividual4,921US$53.37
24 Oct 24SellUS$1,802,808Tighe ReardonIndividual34,799US$52.77
23 Oct 24SellUS$25,244,312Avalon Ventures, LLCCompany492,469US$53.36
23 Oct 24SellUS$408,358Sanford MadiganIndividual7,954US$51.34
23 Oct 24SellUS$350,101Sergio DuronIndividual6,806US$51.44
23 Oct 24SellUS$2,419,661Avalon Bio VenturesCompany47,203US$53.36
18 Oct 24SellUS$21,101,095Avalon Ventures, LLCCompany420,066US$51.18
18 Oct 24SellUS$2,022,474Avalon Bio VenturesCompany40,262US$51.18
18 Oct 24BuyUS$53,700,000RA Capital Management, L.P.Company1,200,000US$44.75
18 Oct 24SellUS$49,003,174Avalon Ventures, LLCCompany1,095,043US$44.75
18 Oct 24SellUS$4,696,826Avalon Bio VenturesCompany104,957US$44.75
17 Oct 24SellUS$26,155Jay LichterIndividual516US$50.80
30 Sep 24SellUS$5,221Jay LichterIndividual113US$46.24
27 Sep 24SellUS$12,924,676Avalon Ventures, LLCCompany275,255US$47.77
27 Sep 24SellUS$1,239,338Avalon Bio VenturesCompany26,394US$47.77
27 Sep 24SellUS$145,750Avalon Ventures, LLCCompany3,053US$47.74
27 Sep 24SellUS$13,988Avalon Bio VenturesCompany293US$47.74
12 Sep 24SellUS$1,850,216Avalon Bio VenturesCompany39,455US$47.00
12 Sep 24SellUS$19,303,403Avalon Ventures, LLCCompany411,636US$47.00
09 Sep 24SellUS$9,198,378Avalon Ventures, LLCCompany219,009US$42.00
09 Sep 24SellUS$3,513Jay LichterIndividual83US$42.33
09 Sep 24SellUS$881,622Avalon Bio VenturesCompany20,991US$42.00
31 Jul 24SellUS$61,511,990OrbiMed Advisors LLCCompany1,312,787US$55.01
03 Jun 24SellUS$74,942,019Avalon Ventures, LLCCompany1,368,804US$54.75
03 Jun 24SellUS$7,182,981Avalon Bio VenturesCompany131,196US$54.75
02 Mar 24SellUS$757,732Sanford MadiganIndividual16,341US$46.37
02 Mar 24SellUS$560,125Sergio DuronIndividual12,343US$45.38

Volume di insider trading

Acquisto da parte di insider: JANX insider hanno venduto azioni solo negli ultimi 3 mesi.

Ripartizione della proprietà

Qual è l'assetto proprietario di JANX?
Tipo di proprietarioNumero di azioniPercentuale di proprietà
Singoli insider4.109.8487,66%
Società VC/PE10.365.65219,3%
Istituzioni39.160.07773%

Diluizione delle azioni: Gli azionisti sono stati diluiti nell'ultimo anno, con un totale di azioni in circolazione in crescita del 13.7%.

I principali azionisti

I primi 25 azionisti possiedono 90.27% della società
ProprietàNomeAzioniValore attualeVariazione %Portafoglio %
19,8%
RA Capital Management, L.P.
10.365.652US$521.5m13,1%6,0%
14,9%
FMR LLC
7.824.671US$393.7m0,61%0,02%
5,72%
Klaus Dorner
2.999.990US$150.9m-21,7%Nessun dato
4,97%
Paradigm Biocapital Advisors LP
2.608.574US$131.2m8,66%4,28%
4,81%
Janus Henderson Group plc
2.523.406US$127.0m40%0,05%
4,62%
BlackRock, Inc.
2.422.636US$121.9m3,35%Nessun dato
3,95%
Adage Capital Management, L.P.
2.075.000US$104.4m-10,9%0,16%
3,56%
Avalon Ventures, LLC
1.869.633US$94.1m-67,2%81,51%
3,52%
The Vanguard Group, Inc.
1.847.930US$93.0m18,3%Nessun dato
3,05%
Woodline Partners LP
1.600.263US$80.5m432%0,62%
2,8%
EcoR1 Capital, LLC
1.469.818US$73.9m0%2,41%
2,59%
State Street Global Advisors, Inc.
1.361.178US$68.5m-2,86%Nessun dato
2,4%
OrbiMed Advisors LLC
1.258.566US$63.3m-57,8%0,8%
2%
Cormorant Asset Management, LP
1.050.000US$52.8m0%2,35%
1,92%
Citadel Advisors LLC
1.009.768US$50.8m-35,2%0,05%
1,91%
Logos Global Management, L.P.
1.000.000US$50.3m33,3%5,56%
1,34%
Lord, Abbett & Co. LLC
703.481US$35.4m0,12%0,1%
1,26%
Geode Capital Management, LLC
662.594US$33.3m6,17%Nessun dato
1,07%
Avidity Partners Management, L.P.
562.000US$28.3m-33,1%1,45%
0,92%
Vestal Point Capital, LP
485.000US$24.4m-33,1%1,84%
0,9%
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
471.736US$23.7m0%0,2%
0,75%
Point72 Asset Management, L.P.
395.875US$19.9m190%0,05%
0,54%
David Campbell
282.054US$14.2m-89,3%Nessun dato
0,51%
Northern Trust Global Investments
266.498US$13.4m37,1%Nessun dato
0,49%
Goldman Sachs Group, Investment Banking and Securities Investments
257.400US$12.9m-14,2%0,01%